These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 33356699

  • 1. Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients.
    Folta A, Jurcek T, Kubesova B, Zackova D, Semerad L, Mayer J, Jeziskova I.
    Leuk Lymphoma; 2021 May; 62(5):1239-1242. PubMed ID: 33356699
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Initial Rate of BCR::ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia.
    Branford S.
    Turk J Haematol; 2022 Aug 25; 39(3):204-205. PubMed ID: 35699277
    [No Abstract] [Full Text] [Related]

  • 5. International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: first report from India.
    Balasubramanian P, Chendamarai E, Markose P, Fletcher L, Branford S, George B, Mathews V, Chandy M, Srivastava A.
    Acta Haematol; 2012 Aug 25; 127(3):135-42. PubMed ID: 22249155
    [Abstract] [Full Text] [Related]

  • 6. Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?
    Langabeer SE, Bhreathnach Ú, Cahill MR, Elhassadi E, Ní Loingsigh S, Conneally E, Enright H.
    Blood Cells Mol Dis; 2021 Mar 25; 87():102521. PubMed ID: 33254033
    [No Abstract] [Full Text] [Related]

  • 7. Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor.
    Fava C, Rege-Cambrin G, Dogliotti I, Gottardi E, Berchialla P, Di Gioacchino B, Crasto F, Lorenzatti R, Volpengo A, Daraio F, Fantino C, Saglio G.
    Clin Lymphoma Myeloma Leuk; 2016 Aug 25; 16 Suppl():S96-S100. PubMed ID: 27131622
    [Abstract] [Full Text] [Related]

  • 8. A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia.
    Jin C, Zhu X, Xiao M, Liu S, Liu X, Liu J, Xu X, Yi S, Meng L.
    Ann Lab Med; 2018 Mar 25; 38(2):169-171. PubMed ID: 29214763
    [No Abstract] [Full Text] [Related]

  • 9. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
    Alikian M, Whale AS, Akiki S, Piechocki K, Torrado C, Myint T, Cowen S, Griffiths M, Reid AG, Apperley J, White H, Huggett JF, Foroni L.
    Clin Chem; 2017 Feb 25; 63(2):525-531. PubMed ID: 27979961
    [Abstract] [Full Text] [Related]

  • 10. Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.
    Ha J, Cheong JW, Shin S, Lee ST, Choi JR.
    Ann Lab Med; 2016 May 25; 36(3):287-9. PubMed ID: 26915625
    [No Abstract] [Full Text] [Related]

  • 11. A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia.
    McCarron SL, Haslam K, Kelly J, Duggan C, Langabeer SE.
    Int J Lab Hematol; 2012 Feb 25; 34(1):e1-2. PubMed ID: 21692997
    [No Abstract] [Full Text] [Related]

  • 12. BCR-ABL1 mutation screening in chronic myeloid leukaemia: is next now?
    Soverini S, Martelli M, Bavaro L.
    Lancet Haematol; 2019 May 25; 6(5):e236-e237. PubMed ID: 31036315
    [No Abstract] [Full Text] [Related]

  • 13. Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient.
    Zámečníkova A, Al Bahar S, Pandita R.
    Hematology; 2012 Nov 25; 17(6):321-4. PubMed ID: 22989955
    [Abstract] [Full Text] [Related]

  • 14. [Molecular analysis of the BCR-ABL1 fusion gene in a chronic myeloid leukemia patient with BCR-ABL1 International Scale-undetectable disease].
    Kawamata N, Watanabe R.
    Rinsho Ketsueki; 2019 Nov 25; 60(7):767-772. PubMed ID: 31391364
    [Abstract] [Full Text] [Related]

  • 15. Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts.
    Xue M, Wang Q, Huo L, Wen L, Yang X, Wu Q, Pan J, Cen J, Ruan C, Wu D, Chen S.
    Leuk Lymphoma; 2019 Dec 25; 60(12):3051-3057. PubMed ID: 31258010
    [Abstract] [Full Text] [Related]

  • 16. CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene.
    Diamond JM, de Almeida AM, Belo HJ, da Costa MP, Cabeçadas JM, Abecasis MM.
    Ann Hematol; 2016 Dec 25; 95(12):2101-2104. PubMed ID: 27699446
    [No Abstract] [Full Text] [Related]

  • 17. Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
    El Missiry M, Hjorth-Hansen H, Richter J, Olson-Strömberg U, Stenke L, Porkka K, Kreutzman A, Mustjoki S.
    PLoS One; 2017 Dec 25; 12(1):e0171041. PubMed ID: 28135325
    [Abstract] [Full Text] [Related]

  • 18. Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia.
    Lee J, Kim DS, Lee HS, Choi SI, Cho YG.
    Ann Lab Med; 2017 Jan 25; 37(1):74-76. PubMed ID: 27834071
    [No Abstract] [Full Text] [Related]

  • 19. Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.
    Brown JT, Beldorth IJ, Laosinchai-Wolf W, Fahey ME, Jefferson KL, Ruskin AK, Roth JJ, Cai L, Watt CD, Press RD, Yang F, Hedges JB, Andruss BF.
    J Mol Diagn; 2019 Jul 25; 21(4):718-733. PubMed ID: 31026597
    [Abstract] [Full Text] [Related]

  • 20. Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia.
    Inokuchi K, Dan K.
    J Nippon Med Sch; 2001 Aug 25; 68(4):292-3. PubMed ID: 11505275
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.